Why We Continue to Back Angle: Angle Health Raises $600M at a $2.7B Valuation

By Bruce Taragin, managing director, and Jared Katzen, vice president

Angle Health, the first AI-native healthcare benefits platform, today announced a $600 million equity financing—a $200 million Series C plus a $400 million tender offer—at a $2.7 billion valuation, in a round led by Vitruvian Partners with participation from new investor Town Hall Ventures and existing investors Blumberg Capital, Portage, PruVen Capital and Y Combinator. 

Blumberg Capital led Angle’s Seed round in 2020 and has returned for every round since—Series A, last December’s $134 million Series B, and now Series C. It’s been a pleasure to watch co-founders Ty Wang and Anirban Gangopadhyay and the Angle team build steadily toward this point. 

What stood out early was not only Ty and Anirban’s ability as founders, but how personal the mission was to them: creating greater transparency and better pricing for employees while improving health outcomes. Over the course of our partnership, they have also proven to be thoughtful communicators and even better listeners. Those qualities have remained consistent as they’ve scaled Angle, and we believe they are still early in their mission to make healthcare more affordable while improving outcomes.

Why now

Employers are facing the largest increase in health insurance costs in two decades and small and midsize businesses are absorbing the worst of it, stuck choosing between limited, confusing, and costly plans for their employees, a dynamic that touches nearly every American family given that small businesses employ half the country’s workforce and have long been an afterthought for an insurance industry built around large-group underwriting.

Angle built its AI-native platform specifically for this gap, and the Benefit Builder platform is a good example of what that looks like in practice: brokers can generate firm, underwritten quotes in minutes instead of weeks, customize plans in real time, and pull from the industry’s first Health Scorecard, bringing a level of transparency to small-group underwriting that legacy carriers simply don’t offer.

The numbers behind the round

Angle enters this next phase from a position of exceptional strength. The Angle Health team has consistently met and exceeded their forecasts nearly every quarter since we invested. Over the past year, the company has achieved 120% year-over-year growth since its previous financing, delivered four consecutive quarters of profitability across both EBITDA and GAAP net income, expanded to support over 5,000 employers in 47 states, and reached nearly $1 billion in annualized premium-equivalents. Crucially, Angle’s median renewal rate increases have averaged just 5–7%, significantly outperforming the broader 18% SMB median, which continues to serve as a key driver of strong client retention.

We are thrilled to continue backing Angle in this exciting next chapter. Ty, Anirban, Andy, and the entire Angle team are demonstrating firsthand that an exceptional healthcare experience and cost-efficiency can go hand in hand. By leveraging technology and AI, they are delivering a truly transformational experience for workers at companies of all sizes across the country.